论文信息 - Ganitumab (AMG 479) Inhibits IGF-II–Dependent Ovarian Cancer Growth and Potentiates Platinum-Based Chemotherapy - 字舞流文

Ganitumab (AMG 479) Inhibits IGF-II–Dependent Ovarian Cancer Growth and Potentiates Platinum-Based Chemotherapy

V. Velculescu | D. Slamon | G. Konecny | F. Calzone | S. Vonderfecht | P. Beltran | Petia Mitchell | Y. Chung | E. Cajulis | Brian Belmontes | Guorong Yang | J. Qi | Gordon Moody | Chi-Ming Li | Jingwei Qi